,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0053884659389882,0.0633585030462752,0,0,235.0235294117647,1227.644124299904,NRG1
32,GO_Biological_Process_2018,posttranscriptional gene silencing by RNA (GO:0035194),1/18,0.0160833123117468,0.0633585030462752,0,0,69.08304498269896,285.3111137768628,LIMD1
31,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.0160833123117468,0.0633585030462752,0,0,69.08304498269896,285.3111137768628,NRG1
30,GO_Biological_Process_2018,regulation of canonical Wnt signaling pathway (GO:0060828),2/213,0.0154393778286823,0.0633585030462752,0,0,11.712677725118484,48.85163485318962,LIMD1;RNF220
29,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0151962391911868,0.0633585030462752,0,0,73.40441176470588,307.3227868353231,NRG1
28,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.0143084109196949,0.0633585030462752,0,0,78.30196078431372,332.5412031884909,NRG1
27,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.0143084109196949,0.0633585030462752,0,0,78.30196078431372,332.5412031884909,NRG1
26,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.01341982690512,0.0633585030462752,0,0,83.89915966386555,361.6911269349327,NRG1
25,GO_Biological_Process_2018,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.01341982690512,0.0633585030462752,0,0,83.89915966386555,361.6911269349327,KCND3
24,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.01341982690512,0.0633585030462752,0,0,83.89915966386555,361.6911269349327,NRG1
23,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.01341982690512,0.0633585030462752,0,0,83.89915966386555,361.6911269349327,NRG1
22,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.0125304865571366,0.0633585030462752,0,0,90.3574660633484,395.7287161899813,NRG1
21,GO_Biological_Process_2018,gliogenesis (GO:0042063),1/14,0.0125304865571366,0.0633585030462752,0,0,90.3574660633484,395.7287161899813,NFIB
20,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.0125304865571366,0.0633585030462752,0,0,90.3574660633484,395.7287161899813,NRG1
19,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.0125304865571366,0.0633585030462752,0,0,90.3574660633484,395.7287161899813,NRG1
18,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.011640389286531,0.0633585030462752,0,0,97.8921568627451,435.94063546940737,NRG1
17,GO_Biological_Process_2018,membrane repolarization (GO:0086009),1/13,0.011640389286531,0.0633585030462752,0,0,97.8921568627451,435.94063546940737,KCND3
7,GO_Biological_Process_2018,potassium ion export (GO:0071435),1/9,0.0080724193100501,0.0633585030462752,0,0,146.86764705882354,707.7995527019895,KCND3
2,GO_Biological_Process_2018,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0071785287204102,0.0633585030462752,0,0,167.85714285714286,828.6537822644398,KCND3
3,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0071785287204102,0.0633585030462752,0,0,167.85714285714286,828.6537822644398,NRG1
4,GO_Biological_Process_2018,osteoblast development (GO:0002076),1/8,0.0071785287204102,0.0633585030462752,0,0,167.85714285714286,828.6537822644398,LIMD1
5,GO_Biological_Process_2018,negative regulation of hippo signaling (GO:0035331),1/8,0.0071785287204102,0.0633585030462752,0,0,167.85714285714286,828.6537822644398,LIMD1
6,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0071785287204102,0.0633585030462752,0,0,167.85714285714286,828.6537822644398,NRG1
16,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),2/183,0.0115703292352687,0.0633585030462752,0,0,13.674723756906078,60.97984993065522,PTPRB;LIMD1
1,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0062838777740325,0.0633585030462752,0,0,195.843137254902,992.8792720611536,NRG1
8,GO_Biological_Process_2018,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,0.0080724193100501,0.0633585030462752,0,0,146.86764705882354,707.7995527019895,NFIB
10,GO_Biological_Process_2018,positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.0098579216348164,0.0633585030462752,0,0,117.48235294117649,542.7073703814344,LIMD1
11,GO_Biological_Process_2018,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0098579216348164,0.0633585030462752,0,0,117.48235294117649,542.7073703814344,KCND3
12,GO_Biological_Process_2018,regulation of hippo signaling (GO:0035330),1/11,0.0098579216348164,0.0633585030462752,0,0,117.48235294117649,542.7073703814344,LIMD1
13,GO_Biological_Process_2018,membrane repolarization during action potential (GO:0086011),1/11,0.0098579216348164,0.0633585030462752,0,0,117.48235294117649,542.7073703814344,KCND3
14,GO_Biological_Process_2018,cytoplasmic mRNA processing body assembly (GO:0033962),1/11,0.0098579216348164,0.0633585030462752,0,0,117.48235294117649,542.7073703814344,LIMD1
15,GO_Biological_Process_2018,viral RNA genome replication (GO:0039694),1/12,0.0107495345067081,0.0633585030462752,0,0,106.79679144385028,484.0984098875249,ATG16L1
9,GO_Biological_Process_2018,central nervous system projection neuron axonogenesis (GO:0021952),1/10,0.0089655500933473,0.0633585030462752,0,0,130.54248366013073,615.425022203049,NFIB
33,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.01696963087688,0.0648838827645412,0,0,65.24183006535948,265.9472259849427,NRG1
34,GO_Biological_Process_2018,positive regulation of gene silencing by miRNA (GO:2000637),1/20,0.0178551954764704,0.066319297484033,0,0,61.80495356037152,248.79341471282052,LIMD1
35,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0196240651712844,0.0708646797851937,0,0,55.91316526610644,219.7945772360195,NRG1
36,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0213899261577365,0.0751537946082634,0,0,51.0460358056266,196.26359569838613,NRG1
37,GO_Biological_Process_2018,glial cell differentiation (GO:0010001),1/25,0.0222717298790694,0.076192760112606,0,0,48.91666666666666,186.10038260880103,NFIB
38,GO_Biological_Process_2018,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),1/26,0.0231527832149216,0.0771759440497388,0,0,46.95764705882353,176.82560723797164,NFIB
39,GO_Biological_Process_2018,negative regulation of osteoblast differentiation (GO:0045668),1/27,0.0240330867565966,0.0781075319589389,0,0,45.14932126696833,168.33128827465845,LIMD1
196,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
195,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
194,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.01341982690512,0.0783056460945186,0,0,83.89915966386555,361.6911269349327,NRG1
193,GO_Biological_Process_2017b,membrane repolarization during SA node cell action potential (GO:0086052),1/15,0.01341982690512,0.0783056460945186,0,0,83.89915966386555,361.6911269349327,KCND3
192,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.0125304865571366,0.0783056460945186,0,0,90.3574660633484,395.7287161899813,NRG1
191,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.0125304865571366,0.0783056460945186,0,0,90.3574660633484,395.7287161899813,NRG1
189,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.011640389286531,0.0783056460945186,0,0,97.8921568627451,435.94063546940737,NRG1
197,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
188,GO_Biological_Process_2017b,cytoplasmic mRNA processing body assembly (GO:0033962),1/13,0.011640389286531,0.0783056460945186,0,0,97.8921568627451,435.94063546940737,LIMD1
187,GO_Biological_Process_2017b,negative regulation of hippo signaling (GO:0035331),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,LIMD1
186,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,NRG1
185,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,NRG1
184,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,NRG1
190,GO_Biological_Process_2017b,membrane repolarization during AV node cell action potential (GO:0086049),1/13,0.011640389286531,0.0783056460945186,0,0,97.8921568627451,435.94063546940737,KCND3
198,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
200,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
183,GO_Biological_Process_2017b,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,KCND3
214,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,PTPRB
213,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
212,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
211,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
210,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
209,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
199,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
208,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
206,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
205,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
204,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
203,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
202,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,NRG1
201,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
207,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0143084109196949,0.0783056460945186,0,0,78.30196078431372,332.5412031884909,PTPRB
182,GO_Biological_Process_2017b,membrane repolarization during bundle of His cell action potential (GO:0086050),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,KCND3
163,GO_Biological_Process_2017b,potassium ion export (GO:0071435),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,KCND3
180,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,NRG1
176,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,NRG1
175,GO_Biological_Process_2017b,negative stranded viral RNA replication (GO:0039689),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,ATG16L1
174,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,NRG1
173,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.0089655500933473,0.0783056460945186,0,0,130.54248366013073,615.425022203049,NRG1
172,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.0089655500933473,0.0783056460945186,0,0,130.54248366013073,615.425022203049,NRG1
171,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.0089655500933473,0.0783056460945186,0,0,130.54248366013073,615.425022203049,NRG1
170,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.0089655500933473,0.0783056460945186,0,0,130.54248366013073,615.425022203049,NRG1
169,GO_Biological_Process_2017b,membrane repolarization during Purkinje myocyte action potential (GO:0086051),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,KCND3
168,GO_Biological_Process_2017b,glial cell differentiation (GO:0010001),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,NFIB
167,GO_Biological_Process_2017b,potassium ion export from cell (GO:0098668),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,KCND3
166,GO_Biological_Process_2017b,radial glial cell differentiation (GO:0060019),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,NFIB
165,GO_Biological_Process_2017b,glial cell development (GO:0021782),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,NFIB
164,GO_Biological_Process_2017b,cardiac muscle cell membrane repolarization (GO:0099622),1/9,0.0080724193100501,0.0783056460945186,0,0,146.86764705882354,707.7995527019895,KCND3
215,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,PTPRB
162,GO_Biological_Process_2017b,cardiac glial cell differentiation (GO:0060950),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,NFIB
161,GO_Biological_Process_2017b,glial cell fate commitment (GO:0021781),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,NFIB
160,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,NRG1
179,GO_Biological_Process_2017b,positive regulation of miRNA mediated inhibition of translation (GO:1905618),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,LIMD1
147,GO_Biological_Process_2017b,phosphorylation (GO:0016310),2/46,0.0007734351437291583,0.0783056460945186,0,0,56.64204545454545,405.82149239611823,PTPRB;LIMD1
148,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0053884659389882,0.0783056460945186,0,0,235.0235294117647,1227.644124299904,NRG1
149,GO_Biological_Process_2017b,lateral line nerve glial cell differentiation (GO:0048895),1/6,0.0053884659389882,0.0783056460945186,0,0,235.0235294117647,1227.644124299904,NFIB
150,GO_Biological_Process_2017b,glial cell differentiation involved in amphid sensory organ development (GO:0003398),1/6,0.0053884659389882,0.0783056460945186,0,0,235.0235294117647,1227.644124299904,NFIB
151,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
181,GO_Biological_Process_2017b,mRNA cleavage involved in gene silencing by miRNA (GO:0035279),1/12,0.0107495345067081,0.0783056460945186,0,0,106.79679144385028,484.0984098875249,LIMD1
152,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
154,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
155,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
156,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
157,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,NRG1
158,GO_Biological_Process_2017b,osteoblast development (GO:0002076),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,LIMD1
159,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0071785287204102,0.0783056460945186,0,0,167.85714285714286,828.6537822644398,NRG1
153,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0062838777740325,0.0783056460945186,0,0,195.843137254902,992.8792720611536,NRG1
216,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,NRG1
178,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,NRG1
218,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,NRG1
177,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.0098579216348164,0.0783056460945186,0,0,117.48235294117649,542.7073703814344,NRG1
229,GO_Biological_Process_2017b,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/19,0.01696963087688,0.0783056460945186,0,0,65.24183006535948,265.9472259849427,LIMD1
228,GO_Biological_Process_2017b,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),1/19,0.01696963087688,0.0783056460945186,0,0,65.24183006535948,265.9472259849427,KCND3
227,GO_Biological_Process_2017b,miRNA mediated inhibition of translation (GO:0035278),1/19,0.01696963087688,0.0783056460945186,0,0,65.24183006535948,265.9472259849427,LIMD1
226,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.01696963087688,0.0783056460945186,0,0,65.24183006535948,265.9472259849427,PTPRB
225,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.01696963087688,0.0783056460945186,0,0,65.24183006535948,265.9472259849427,PTPRB
217,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,PTPRB
223,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.0160833123117468,0.0783056460945186,0,0,69.08304498269896,285.3111137768628,NRG1
222,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0160833123117468,0.0783056460945186,0,0,69.08304498269896,285.3111137768628,PTPRB
221,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0160833123117468,0.0783056460945186,0,0,69.08304498269896,285.3111137768628,PTPRB
220,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,NRG1
219,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0151962391911868,0.0783056460945186,0,0,73.40441176470588,307.3227868353231,PTPRB
224,GO_Biological_Process_2017b,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/18,0.0160833123117468,0.0783056460945186,0,0,69.08304498269896,285.3111137768628,LIMD1
43,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.0266695046006179,0.0787962635927348,0,0,40.47261663286004,146.68225415832842,NRG1
42,GO_Biological_Process_2018,hippo signaling (GO:0035329),1/30,0.0266695046006179,0.0787962635927348,0,0,40.47261663286004,146.68225415832842,LIMD1
41,GO_Biological_Process_2018,cardiac muscle cell action potential (GO:0086001),1/29,0.02579144685281,0.0787962635927348,0,0,41.92016806722689,153.33191684558912,KCND3
40,GO_Biological_Process_2018,chondrocyte differentiation (GO:0002062),1/28,0.0249126411012733,0.0787962635927348,0,0,43.474945533769066,160.52601632867996,NFIB
44,GO_Biological_Process_2018,gene silencing by miRNA (GO:0035195),1/31,0.0275468149406694,0.0795796876063785,0,0,39.12156862745098,140.51952455455398,LIMD1
230,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.0178551954764704,0.0814111888986687,0,0,61.80495356037152,248.79341471282052,PTPRB
45,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.030174267482518,0.0823738212298614,0,0,35.559714795008915,124.48623298308226,NRG1
46,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.030174267482518,0.0823738212298614,0,0,35.559714795008915,124.48623298308226,NRG1
47,GO_Biological_Process_2018,regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.0310485941558708,0.0823738212298614,0,0,34.5121107266436,119.83301120641356,KCND3
48,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0310485941558708,0.0823738212298614,0,0,34.5121107266436,119.83301120641356,NRG1
233,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0187400067082949,0.0824991099916892,0,0,58.71176470588235,233.50224496360525,PTPRB
232,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0187400067082949,0.0824991099916892,0,0,58.71176470588235,233.50224496360525,NRG1
231,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0187400067082949,0.0824991099916892,0,0,58.71176470588235,233.50224496360525,NRG1
49,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0319221763964905,0.0829976586308753,0,0,33.52436974789916,115.4731604004656,NRG1
236,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0196240651712844,0.0835112995622436,0,0,55.91316526610644,219.7945772360195,PTPRB
234,GO_Biological_Process_2017b,Schwann cell differentiation (GO:0014037),1/22,0.0196240651712844,0.0835112995622436,0,0,55.91316526610644,219.7945772360195,NFIB
235,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0196240651712844,0.0835112995622436,0,0,55.91316526610644,219.7945772360195,NRG1
238,GO_Biological_Process_2017b,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/23,0.0205073714570783,0.0835566305112873,0,0,53.36898395721925,207.44368622737056,KCND3
237,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0205073714570783,0.0835566305112873,0,0,53.36898395721925,207.44368622737056,PTPRB
239,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0205073714570783,0.0835566305112873,0,0,53.36898395721925,207.44368622737056,PTPRB
240,GO_Biological_Process_2017b,membrane repolarization during action potential (GO:0086011),1/23,0.0205073714570783,0.0835566305112873,0,0,53.36898395721925,207.44368622737056,KCND3
241,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0213899261577365,0.0862351759832956,0,0,51.0460358056266,196.26359569838613,NRG1
51,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",3/813,0.0346237210751129,0.0865593026877824,0,0,4.733827160493827,15.920884438512328,NFIB;NRG1;LIMD1
50,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),1/39,0.0345384624837867,0.0865593026877824,0,0,30.87306501547988,103.9089106040704,NRG1
52,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),1/40,0.035409072945574,0.0868524430740496,0,0,30.07993966817496,100.49067723322013,NRG1
244,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
243,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
242,GO_Biological_Process_2017b,chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413),1/25,0.0222717298790694,0.0869364310913234,0,0,48.91666666666666,186.10038260880103,NFIB
247,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
248,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
245,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
246,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0231527832149216,0.0869364310913234,0,0,46.95764705882353,176.82560723797164,NRG1
251,GO_Biological_Process_2017b,chondrocyte development (GO:0002063),1/27,0.0240330867565966,0.0876635450264428,0,0,45.14932126696833,168.33128827465845,NFIB
250,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0240330867565966,0.0876635450264428,0,0,45.14932126696833,168.33128827465845,NRG1
249,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0240330867565966,0.0876635450264428,0,0,45.14932126696833,168.33128827465845,NRG1
252,GO_Biological_Process_2017b,polynucleotide dephosphorylation (GO:0098501),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,PTPRB
253,GO_Biological_Process_2017b,glucose 1-phosphate phosphorylation (GO:0006009),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,LIMD1
254,GO_Biological_Process_2017b,negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,NFIB
255,GO_Biological_Process_2017b,phosphorylated carbohydrate dephosphorylation (GO:0046838),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,PTPRB
256,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,PTPRB
257,GO_Biological_Process_2017b,deoxyribose 5-phosphate phosphorylation (GO:0006019),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,LIMD1
258,GO_Biological_Process_2017b,organic acid phosphorylation (GO:0031388),1/30,0.0266695046006179,0.0912001809110417,0,0,40.47261663286004,146.68225415832842,LIMD1
53,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.0380164579400951,0.0915211024483773,0,0,27.92717086834734,91.3144790197023,NRG1
260,GO_Biological_Process_2017b,phosphoanandamide dephosphorylation (GO:0035644),1/31,0.0275468149406694,0.0925476326515474,0,0,39.12156862745098,140.51952455455398,PTPRB
259,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0275468149406694,0.0925476326515474,0,0,39.12156862745098,140.51952455455398,NRG1
56,GO_Biological_Process_2018,cartilage development (GO:0051216),1/46,0.0406171857845244,0.0926356868769856,0,0,26.06143790849673,83.48948444789488,NFIB
55,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0406171857845244,0.0926356868769856,0,0,26.06143790849673,83.48948444789488,NRG1
54,GO_Biological_Process_2018,negative regulation of ossification (GO:0030279),1/45,0.0397510152021215,0.0926356868769856,0,0,26.655080213903744,85.9658295948253,LIMD1
261,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0284233784701102,0.0946622082961063,0,0,37.85768500948767,134.79392621731594,NRG1
57,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.0432112724444188,0.0958313667369472,0,0,24.42892156862745,76.74721626832032,RNF220
59,GO_Biological_Process_2018,organelle assembly (GO:0070925),2/376,0.0442298615708987,0.0958313667369472,0,0,6.553475935828877,20.436065217728228,ATG16L1;LIMD1
58,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0440744949316926,0.0958313667369472,0,0,23.92917166866747,74.70385911458476,NRG1
262,GO_Biological_Process_2017b,regulation of heart rate by cardiac conduction (GO:0086091),1/34,0.030174267482518,0.0987755935538837,0,0,35.559714795008915,124.48623298308226,KCND3
263,GO_Biological_Process_2017b,substrate localization to autophagosome (GO:0061753),1/34,0.030174267482518,0.0987755935538837,0,0,35.559714795008915,124.48623298308226,ATG16L1
265,GO_Biological_Process_2017b,autophagosome assembly (GO:0000045),1/35,0.0310485941558708,0.0990967630141544,0,0,34.5121107266436,119.83301120641356,ATG16L1
266,GO_Biological_Process_2017b,carbohydrate phosphorylation (GO:0046835),1/35,0.0310485941558708,0.0990967630141544,0,0,34.5121107266436,119.83301120641356,LIMD1
264,GO_Biological_Process_2017b,nucleotide phosphorylation (GO:0046939),1/35,0.0310485941558708,0.0990967630141544,0,0,34.5121107266436,119.83301120641356,LIMD1
267,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0319221763964905,0.0993999476411046,0,0,33.52436974789916,115.4731604004656,NRG1
268,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0319221763964905,0.0993999476411046,0,0,33.52436974789916,115.4731604004656,NRG1
269,GO_Biological_Process_2017b,deadenylation involved in gene silencing by miRNA (GO:0098806),1/36,0.0319221763964905,0.0993999476411046,0,0,33.52436974789916,115.4731604004656,LIMD1
270,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.0327950148043916,0.1012942795974353,0,0,32.591503267973856,111.38077026649428,NRG1
273,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),1/38,0.0336671099659209,0.1015315206058875,0,0,31.70906200317965,107.5328454820737,NRG1
271,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0336671099659209,0.1015315206058875,0,0,31.70906200317965,107.5328454820737,NRG1
272,GO_Biological_Process_2017b,lipid phosphorylation (GO:0046834),1/38,0.0336671099659209,0.1015315206058875,0,0,31.70906200317965,107.5328454820737,LIMD1
274,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),1/39,0.0345384624837867,0.1025444273743437,0,0,30.87306501547988,103.9089106040704,NRG1
275,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0345384624837867,0.1025444273743437,0,0,30.87306501547988,103.9089106040704,NRG1
276,GO_Biological_Process_2017b,phospholipid dephosphorylation (GO:0046839),1/40,0.035409072945574,0.1035242361691212,0,0,30.07993966817496,100.49067723322013,PTPRB
277,GO_Biological_Process_2017b,engulfment of target by autophagosome (GO:0061736),1/40,0.035409072945574,0.1035242361691212,0,0,30.07993966817496,100.49067723322013,ATG16L1
279,GO_Biological_Process_2017b,chondrocyte differentiation (GO:0002062),1/41,0.0362789419461595,0.1044724418449556,0,0,29.326470588235296,97.26176223664352,NFIB
278,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),1/41,0.0362789419461595,0.1044724418449556,0,0,29.326470588235296,97.26176223664352,NRG1
60,GO_Biological_Process_2018,autophagosome organization (GO:1905037),1/56,0.0492384039303871,0.104934303458202,0,0,21.31229946524064,64.173068346434,ATG16L1
61,GO_Biological_Process_2018,autophagosome assembly (GO:0000045),1/58,0.0509538444953197,0.1068387061998638,0,0,20.562435500516,61.21097903869968,ATG16L1
280,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0380164579400951,0.108658980530272,0,0,27.92717086834734,91.3144790197023,PTPRB
281,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0388841061194349,0.1095045047334086,0,0,27.276333789329687,88.57088446864675,NRG1
282,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0388841061194349,0.1095045047334086,0,0,27.276333789329687,88.57088446864675,PTPRB
62,GO_Biological_Process_2018,potassium ion transport (GO:0006813),1/61,0.0535215254426699,0.110441242976938,0,0,19.531372549019608,57.18144005818292,KCND3
283,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.0397510152021215,0.1111287505285587,0,0,26.655080213903744,85.9658295948253,NRG1
135,WikiPathways_2019_Human,Nanoparticle triggered autophagic cell death WP2509,1/23,0.0205073714570783,0.1138697909275572,0,0,53.36898395721925,207.44368622737056,ATG16L1
137,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0466597514614696,0.1138697909275572,0,0,22.54524886877828,69.09833217880467,NRG1
138,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,1/53,0.0466597514614696,0.1138697909275572,0,0,22.54524886877828,69.09833217880467,NRG1
139,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,1/55,0.0483795859097418,0.1138697909275572,0,0,21.70806100217865,65.7467122997584,NRG1
140,WikiPathways_2019_Human,Pathways Affected in Adenoid Cystic Carcinoma WP3651,1/65,0.0569348954637786,0.1138697909275572,0,0,18.30698529411765,52.46501611587855,NFIB
136,WikiPathways_2019_Human,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,1/47,0.0414826184608072,0.1138697909275572,0,0,25.493606138107417,81.1329113370927,LIMD1
284,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.0414826184608072,0.1151292961629649,0,0,25.493606138107417,81.1329113370927,NRG1
285,GO_Biological_Process_2017b,photosynthetic phosphorylation (GO:0009777),1/48,0.0423473138141528,0.1166836056893564,0,0,24.94993742177722,78.88796682594588,LIMD1
64,GO_Biological_Process_2018,regulation of gene silencing by miRNA (GO:0060964),1/67,0.0586372175990698,0.1169718211936785,0,0,17.750445632798574,50.34710965358108,LIMD1
63,GO_Biological_Process_2018,negative regulation of epithelial cell proliferation (GO:0050680),1/66,0.0577864196143044,0.1169718211936785,0,0,18.02443438914027,51.38768922197736,NFIB
65,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),2/444,0.0595300690031704,0.1169718211936785,0,0,5.526018099547511,15.590409710594148,NRG1;LIMD1
67,GO_Biological_Process_2018,negative regulation of developmental process (GO:0051093),1/70,0.0611852603166933,0.1169718211936785,0,0,16.97612958226769,47.42874202866335,NFIB
66,GO_Biological_Process_2018,regulation of osteoblast differentiation (GO:0045667),1/69,0.0603366373648496,0.1169718211936785,0,0,17.226643598615915,48.3692416453001,LIMD1
286,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.0432112724444188,0.1182136953300888,0,0,24.42892156862745,76.74721626832032,NRG1
141,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,1/84,0.0729902413804037,0.1182600373680141,0,0,14.10276399716513,36.91299089130259,NRG1
142,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,1/91,0.0788400249120094,0.1182600373680141,0,0,13.001307189542484,33.02766894797317,NRG1
288,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",3/895,0.0441271473747728,0.1190189960882958,0,0,4.280269058295964,13.35735046942683,NRG1;ZNF678;LIMD1
287,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.0440744949316926,0.1190189960882958,0,0,23.92917166866747,74.70385911458476,NRG1
289,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),1/51,0.0449369818711912,0.1203556927039598,0,0,23.44941176470588,72.75166337328601,NRG1
143,WikiPathways_2019_Human,Senescence and Autophagy in Cancer WP615,1/105,0.0904351615790965,0.1205802154387954,0,0,11.243212669683258,27.0188131977752,ATG16L1
68,GO_Biological_Process_2018,gland development (GO:0048732),1/75,0.0654175289767128,0.1232504169126474,0,0,15.825119236883944,43.154546742931096,NRG1
309,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),2/416,0.0530259031730843,0.123920151420764,0,0,5.908212560386473,17.35227108213742,NRG1;LIMD1
307,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),2/413,0.0523455409346631,0.123920151420764,0,0,5.952250608272506,17.558475756772538,NRG1;LIMD1
306,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),2/413,0.0523455409346631,0.123920151420764,0,0,5.952250608272506,17.558475756772538,NRG1;LIMD1
305,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),2/413,0.0523455409346631,0.123920151420764,0,0,5.952250608272506,17.558475756772538,NRG1;LIMD1
302,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
310,GO_Biological_Process_2017b,positive regulation of gene silencing by miRNA (GO:2000637),1/61,0.0535215254426699,0.123920151420764,0,0,19.531372549019608,57.18144005818292,LIMD1
308,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",2/414,0.052571965767079,0.123920151420764,0,0,5.9375,17.48933536218089,NRG1;LIMD1
303,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
312,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),2/419,0.0537095173259708,0.123920151420764,0,0,5.8648081534772185,17.149667096410305,NRG1;RNF220
290,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),1/55,0.0483795859097418,0.123920151420764,0,0,21.70806100217865,65.7467122997584,NRG1
291,GO_Biological_Process_2017b,negative regulation of osteoblast differentiation (GO:0045668),1/56,0.0492384039303871,0.123920151420764,0,0,21.31229946524064,64.173068346434,LIMD1
292,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0500964899328297,0.123920151420764,0,0,20.930672268907564,62.66233736405012,PTPRB
293,GO_Biological_Process_2017b,oxidative phosphorylation (GO:0006119),1/58,0.0509538444953197,0.123920151420764,0,0,20.562435500516,61.21097903869968,LIMD1
294,GO_Biological_Process_2017b,protein localization to pre-autophagosomal structure (GO:0034497),1/58,0.0509538444953197,0.123920151420764,0,0,20.562435500516,61.21097903869968,ATG16L1
295,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.051810468206973,0.123920151420764,0,0,20.20689655172414,59.81570875382696,PTPRB
296,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
297,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
298,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
299,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
300,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
301,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
304,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),2/412,0.0521194796819718,0.123920151420764,0,0,5.967073170731707,17.628026076478744,NRG1;LIMD1
311,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),2/419,0.0537095173259708,0.123920151420764,0,0,5.8648081534772185,17.149667096410305,NRG1;LIMD1
313,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",2/422,0.0543963631343197,0.1243187308603554,0,0,5.8220238095238095,16.950577688742165,NRG1;LIMD1
315,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",2/424,0.054856045732115,0.1243187308603554,0,0,5.793838862559242,16.819762630732004,NRG1;LIMD1
314,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),2/423,0.0546260263910496,0.1243187308603554,0,0,5.807897862232779,16.884981067848866,NRG1;LIMD1
316,GO_Biological_Process_2017b,gene silencing by miRNA (GO:0035195),1/64,0.0560826445470321,0.1259725027195073,0,0,18.598506069094302,53.58097327195968,LIMD1
317,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),2/430,0.0562435978199366,0.1259725027195073,0,0,5.7108644859813085,16.436228122963634,NRG1;LIMD1
318,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),2/432,0.0567089301669923,0.1260466182810821,0,0,5.683720930232558,16.311276359736333,NRG1;LIMD1
319,GO_Biological_Process_2017b,potassium ion transport (GO:0006813),1/65,0.0569348954637786,0.1260466182810821,0,0,18.30698529411765,52.46501611587855,KCND3
69,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/78,0.0679482341709108,0.1261895777459772,0,0,15.206264323911382,40.88978353793229,LIMD1
320,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0577864196143044,0.1271965443234403,0,0,18.02443438914027,51.38768922197736,NRG1
71,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.070472466450265,0.1272419533129785,0,0,14.633823529411766,38.81670264132201,NRG1
70,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),1/80,0.0696317739420862,0.1272419533129785,0,0,14.819806403574088,39.48788238772356,NRG1
330,GO_Biological_Process_2017b,regulation of antisense RNA transcription (GO:0060194),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
339,GO_Biological_Process_2017b,regulation of chromatin silencing (GO:0031935),2/465,0.064584342833928,0.1279864704380803,0,0,5.269708423326134,14.437858968429191,ZNF678;LIMD1
340,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase I promoter (GO:0006356),2/466,0.064828656044354,0.1279864704380803,0,0,5.258081896551724,14.386151769949572,ZNF678;LIMD1
336,GO_Biological_Process_2017b,carbon catabolite regulation of transcription (GO:0045990),2/464,0.0643403551865875,0.1279864704380803,0,0,5.2813852813852815,14.489840903907792,ZNF678;LIMD1
335,GO_Biological_Process_2017b,nitrogen catabolite regulation of transcription (GO:0090293),2/464,0.0643403551865875,0.1279864704380803,0,0,5.2813852813852815,14.489840903907792,ZNF678;LIMD1
334,GO_Biological_Process_2017b,regulation of chromatin-mediated maintenance of transcription (GO:1904499),2/462,0.0638533594430714,0.1279864704380803,0,0,5.3048913043478265,14.59463703197796,ZNF678;LIMD1
333,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),1/73,0.063726788409155,0.1279864704380803,0,0,16.266339869281047,44.783677915691136,NRG1
332,GO_Biological_Process_2017b,regulation of transcription by glucose (GO:0046015),2/461,0.0636103527617239,0.1279864704380803,0,0,5.316721132897603,14.647455296538736,ZNF678;LIMD1
331,GO_Biological_Process_2017b,"regulation of DNA-templated transcription, termination (GO:0031554)",2/461,0.0636103527617239,0.1279864704380803,0,0,5.316721132897603,14.647455296538736,ZNF678;LIMD1
338,GO_Biological_Process_2017b,regulation of DNA-templated transcription in response to stress (GO:0043620),2/465,0.064584342833928,0.1279864704380803,0,0,5.269708423326134,14.437858968429191,ZNF678;LIMD1
329,GO_Biological_Process_2017b,regulation of transcription by galactose (GO:0000409),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
337,GO_Biological_Process_2017b,pre-miRNA export from nucleus (GO:0035281),1/74,0.0645725194547735,0.1279864704380803,0,0,16.042707493956488,43.95647876269956,LIMD1
327,GO_Biological_Process_2017b,regulation of transcription during mitotic cell cycle (GO:0045896),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
321,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0628803352568931,0.1279864704380803,0,0,16.496271748135875,45.63729539644487,NRG1
322,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase V promoter (GO:1904279),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
323,GO_Biological_Process_2017b,chromatin organization involved in regulation of transcription (GO:0034401),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
328,GO_Biological_Process_2017b,"regulation of mating-type specific transcription, DNA-templated (GO:0007532)",2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
325,GO_Biological_Process_2017b,regulation of transcription from mitochondrial promoter (GO:1903108),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
326,GO_Biological_Process_2017b,regulation of transcription by carbon monoxide (GO:0070028),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
324,GO_Biological_Process_2017b,regulation of transcription by pheromones (GO:0009373),2/460,0.0633676744877864,0.1279864704380803,0,0,5.328602620087336,14.700556441279216,ZNF678;LIMD1
341,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase III promoter (GO:0006359),2/469,0.0655635420414442,0.1281165132748629,0,0,5.223501070663811,14.23265879676262,ZNF678;LIMD1
342,GO_Biological_Process_2017b,"regulation of DNA-templated transcription, elongation (GO:0032784)",2/469,0.0655635420414442,0.1281165132748629,0,0,5.223501070663811,14.23265879676262,ZNF678;LIMD1
343,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0662618175517913,0.1288237366616045,0,0,15.613333333333332,42.376795202067306,NRG1
344,GO_Biological_Process_2017b,"regulation of DNA-templated transcription, initiation (GO:2000142)",2/474,0.0667947975851887,0.1292040781572085,0,0,5.166843220338983,13.98214986719412,ZNF678;LIMD1
72,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.0763372567298681,0.1324387000375776,0,0,13.451656524678835,34.60565311468726,NRG1
74,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/512,0.0764069423293717,0.1324387000375776,0,0,4.772549019607843,12.27347706557533,NRG1;LIMD1
73,GO_Biological_Process_2018,negative regulation of translation (GO:0017148),1/88,0.0763372567298681,0.1324387000375776,0,0,13.451656524678835,34.60565311468726,LIMD1
345,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428),1/80,0.0696317739420862,0.1340149217076332,0,0,14.819806403574088,39.48788238772356,LIMD1
144,WikiPathways_2019_Human,Ectoderm Differentiation WP2858,1/138,0.1172235366155797,0.1348413114942376,0,0,8.520824388149421,18.26585775015061,PTPRB
145,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.1236045355363844,0.1348413114942376,0,0,8.047464503042596,16.82457683434384,NRG1
346,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0713124414727928,0.135705157517935,0,0,14.452432824981845,38.16431494463284,NRG1
347,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0721516995917754,0.135705157517935,0,0,14.275466284074604,37.52997870137401,PTPRB
352,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0729902413804037,0.135705157517935,0,0,14.10276399716513,36.91299089130259,NRG1
348,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0721516995917754,0.135705157517935,0,0,14.275466284074604,37.52997870137401,PTPRB
350,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0729902413804037,0.135705157517935,0,0,14.10276399716513,36.91299089130259,NRG1
349,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0729902413804037,0.135705157517935,0,0,14.10276399716513,36.91299089130259,PTPRB
351,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0729902413804037,0.135705157517935,0,0,14.10276399716513,36.91299089130259,NRG1
75,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/93,0.0805049773808957,0.1377058823620584,0,0,12.717391304347826,32.040656856642045,LIMD1
353,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0746651782709374,0.1381486148684494,0,0,13.76955017301038,35.728422579909434,NRG1
355,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),1/89,0.0771722254871189,0.1385125208316496,0,0,13.29812834224599,34.06602362525984,NRG1
356,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/89,0.0771722254871189,0.1385125208316496,0,0,13.29812834224599,34.06602362525984,LIMD1
357,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0771722254871189,0.1385125208316496,0,0,13.29812834224599,34.06602362525984,PTPRB
359,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0780064813617029,0.1385125208316496,0,0,13.148050231328488,33.54019441349092,NRG1
360,GO_Biological_Process_2017b,microtubule cytoskeleton attachment to nuclear envelope (GO:1990933),1/90,0.0780064813617029,0.1385125208316496,0,0,13.148050231328488,33.54019441349092,LIMD1
361,GO_Biological_Process_2017b,septin cytoskeleton organization (GO:0032185),1/91,0.0788400249120094,0.1385125208316496,0,0,13.001307189542484,33.02766894797317,LIMD1
362,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.0788400249120094,0.1385125208316496,0,0,13.001307189542484,33.02766894797317,NRG1
363,GO_Biological_Process_2017b,macroautophagy (GO:0016236),1/91,0.0788400249120094,0.1385125208316496,0,0,13.001307189542484,33.02766894797317,ATG16L1
364,GO_Biological_Process_2017b,selective autophagy (GO:0061912),1/91,0.0788400249120094,0.1385125208316496,0,0,13.001307189542484,33.02766894797317,ATG16L1
358,GO_Biological_Process_2017b,cytoskeleton organization (GO:0007010),1/90,0.0780064813617029,0.1385125208316496,0,0,13.148050231328488,33.54019441349092,LIMD1
354,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0763372567298681,0.1385125208316496,0,0,13.451656524678835,34.60565311468726,PTPRB
366,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0796728567374856,0.1387032005929863,0,0,12.857789269553976,32.527973699604026,PTPRB
365,GO_Biological_Process_2017b,cortical cytoskeleton organization (GO:0030865),1/92,0.0796728567374856,0.1387032005929863,0,0,12.857789269553976,32.527973699604026,LIMD1
368,GO_Biological_Process_2017b,"regulation of transcription, DNA-templated (GO:0006355)",2/529,0.0808464342662682,0.1394783077656789,0,0,4.614563567362429,11.606567806164996,ZNF678;LIMD1
367,GO_Biological_Process_2017b,autophagosome organization (GO:1905037),1/93,0.0805049773808957,0.1394783077656789,0,0,12.717391304347826,32.040656856642045,ATG16L1
370,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.083826359716664,0.1433281061226889,0,0,12.185049019607844,30.20683114705019,PTPRB
369,GO_Biological_Process_2017b,cytoskeletal anchoring at nuclear membrane (GO:0090286),1/97,0.083826359716664,0.1433281061226889,0,0,12.185049019607844,30.20683114705019,LIMD1
372,GO_Biological_Process_2017b,cytoskeletal anchoring at plasma membrane (GO:0007016),1/99,0.0854827987095899,0.1443524610859259,0,0,11.935174069627852,29.35384580236193,LIMD1
373,GO_Biological_Process_2017b,protein lipidation involved in autophagosome assembly (GO:0061739),1/100,0.0863099571505927,0.1443524610859259,0,0,11.81402257872846,28.942114306609312,ATG16L1
374,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068),1/100,0.0863099571505927,0.1443524610859259,0,0,11.81402257872846,28.942114306609312,RNF220
375,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072381),1/100,0.0863099571505927,0.1443524610859259,0,0,11.81402257872846,28.942114306609312,RNF220
371,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0854827987095899,0.1443524610859259,0,0,11.935174069627852,29.35384580236193,NRG1
376,GO_Biological_Process_2017b,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/557,0.0883347455662682,0.1465754125929565,0,0,4.37545045045045,10.617563247702368,ZNF678;LIMD1
377,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.0887871950954723,0.1465754125929565,0,0,11.46482122260669,27.76221178459644,NFIB
378,GO_Biological_Process_2017b,autophagosome maturation (GO:0097352),1/103,0.0887871950954723,0.1465754125929565,0,0,11.46482122260669,27.76221178459644,ATG16L1
76,GO_Biological_Process_2018,metal ion transport (GO:0030001),1/101,0.0871364089944587,0.1471134177828523,0,0,11.69529411764706,28.539797811620943,KCND3
379,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.0896115305088417,0.1473013570166798,0,0,11.352941176470589,27.38637392725137,NFIB
130,KEGG_2019_Human,Adherens junction,1/72,0.0628803352568931,0.1486955362376284,0,0,16.496271748135875,45.63729539644487,PTPRB
131,KEGG_2019_Human,ErbB signaling pathway,1/85,0.0738280674139551,0.1486955362376284,0,0,13.934173669467787,36.31268374332498,NRG1
132,KEGG_2019_Human,Autophagy,1/128,0.1091855755847519,0.1486955362376284,0,0,9.196387216303844,20.36729685335,ATG16L1
133,KEGG_2019_Human,Hippo signaling pathway,1/160,0.1346665906377369,0.1486955362376284,0,0,7.33370329263781,14.70373228235524,LIMD1
134,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.1486955362376284,0.1486955362376284,0,0,6.581920903954802,12.544183208435394,ATG16L1
77,GO_Biological_Process_2018,monovalent inorganic cation transport (GO:0015672),1/104,0.0896115305088417,0.1493525508480696,0,0,11.352941176470589,27.38637392725137,KCND3
78,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.0937226537969026,0.1511839574940383,0,0,10.824618736383442,25.6263685491649,NRG1
79,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0945427716606664,0.1511839574940383,0,0,10.724770642201834,25.296548009342803,NRG1
80,GO_Biological_Process_2018,macroautophagy (GO:0016236),1/110,0.0945427716606664,0.1511839574940383,0,0,10.724770642201834,25.296548009342803,ATG16L1
81,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),1/111,0.0953621885731626,0.1511839574940383,0,0,10.62673796791444,24.97361130786349,NRG1
82,GO_Biological_Process_2018,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/113,0.0969989218002412,0.1519260220967633,0,0,10.4359243697479,24.3475898718272,RNF220
91,GO_Biological_Process_2018,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/631,0.1090865194821871,0.1526249981292232,0,0,3.845985691573927,8.521219568573615,ZNF678;LIMD1
85,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),2/618,0.105347112991476,0.1526249981292232,0,0,3.929788961038961,8.843968612274734,NRG1;LIMD1
84,GO_Biological_Process_2018,regulation of nucleic acid-templated transcription (GO:1903506),2/607,0.1022129288311499,0.1526249981292232,0,0,4.003512396694215,9.13079912903457,ZNF678;LIMD1
83,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.1002640016593071,0.1526249981292232,0,0,10.074036511156187,23.16976571809541,NRG1
92,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),1/128,0.1091855755847519,0.1526249981292232,0,0,9.196387216303844,20.36729685335,NRG1
87,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1067607406651116,0.1526249981292232,0,0,9.420303605313093,21.074773673487663,PTPRB
88,GO_Biological_Process_2018,negative regulation of multicellular organismal process (GO:0051241),1/125,0.1067607406651116,0.1526249981292232,0,0,9.420303605313093,21.074773673487663,NFIB
86,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1059510780315295,0.1526249981292232,0,0,9.49736967957915,21.31948479946905,PTPRB
89,GO_Biological_Process_2018,cytoskeleton organization (GO:0007010),1/126,0.107569710770567,0.1526249981292232,0,0,9.344470588235296,20.83458271705315,LIMD1
90,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),1/127,0.1083779888894848,0.1526249981292232,0,0,9.26984126984127,20.598794838572697,NRG1
380,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.0945427716606664,0.154743083530065,0,0,10.724770642201834,25.296548009342803,NFIB
93,GO_Biological_Process_2018,cellular response to hypoxia (GO:0071456),1/132,0.1124090192777675,0.1554592819798912,0,0,8.913785361472833,19.48206824738867,LIMD1
381,GO_Biological_Process_2017b,regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117),2/583,0.095473894303987,0.1556021341209661,0,0,4.174053356282272,9.804444058740197,ZNF678;LIMD1
382,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),1/113,0.0969989218002412,0.1574177417351372,0,0,10.4359243697479,24.3475898718272,NRG1
383,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.0978162392503257,0.1580743444425095,0,0,10.343050494534095,24.04412406695568,NRG1
94,GO_Biological_Process_2018,positive regulation of Wnt signaling pathway (GO:0030177),1/140,0.118822887239702,0.1625997404332764,0,0,8.39737621667372,17.887429414854076,RNF220
95,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.1220133823045622,0.1652264552040946,0,0,8.160839160839162,17.167341601168975,NRG1
96,GO_Biological_Process_2018,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/148,0.1251929650857193,0.1677843861973558,0,0,7.937174869947979,16.492647814827816,LIMD1
97,GO_Biological_Process_2018,negative regulation of cell differentiation (GO:0045596),1/150,0.126778675360575,0.1681757938456607,0,0,7.82984603237268,16.171078308333918,LIMD1
98,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1283616707475379,0.1685557292644437,0,0,7.725360342812622,15.859418874897433,NRG1
99,GO_Biological_Process_2018,ribonucleoprotein complex assembly (GO:0022618),1/156,0.1315195342897091,0.1709753945766219,0,0,7.524478178368121,15.264155594900606,LIMD1
100,GO_Biological_Process_2018,axon guidance (GO:0007411),1/158,0.133094411192108,0.1713096381680598,0,0,7.427875608842263,14.979771069640403,NFIB
385,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/126,0.107569710770567,0.1723815867160132,0,0,9.344470588235296,20.83458271705315,NRG1
384,GO_Biological_Process_2017b,protein homotrimerization (GO:0070207),1/126,0.107569710770567,0.1723815867160132,0,0,9.344470588235296,20.83458271705315,ATG16L1
101,GO_Biological_Process_2018,negative regulation of intracellular signal transduction (GO:1902532),1/161,0.1354516701926492,0.1726344816180822,0,0,7.2875,14.568735518025488,LIMD1
102,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.1370198116411668,0.1729376263432203,0,0,7.19680464778504,14.304583045111348,NRG1
386,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/128,0.1091855755847519,0.1742419810373334,0,0,9.196387216303844,20.36729685335,LIMD1
387,GO_Biological_Process_2017b,commissural neuron axon guidance (GO:0071679),1/130,0.1107986769436176,0.1760825446863301,0,0,9.052895576835386,19.91673641957648,NFIB
388,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905241),1/133,0.1132131572099071,0.1791761950884067,0,0,8.845811051693405,19.27044802603592,RNF220
103,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.1455966829399851,0.1819958536749814,0,0,6.735464127847671,12.97866635801621,LIMD1
389,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.1164228335754234,0.182506563104744,0,0,8.583910034602075,18.459926845841217,NRG1
390,GO_Biological_Process_2017b,amphisome-lysosome fusion (GO:0061911),1/138,0.1172235366155797,0.182506563104744,0,0,8.520824388149421,18.26585775015061,ATG16L1
391,GO_Biological_Process_2017b,autophagosome-endosome fusion (GO:0061910),1/138,0.1172235366155797,0.182506563104744,0,0,8.520824388149421,18.26585775015061,ATG16L1
392,GO_Biological_Process_2017b,autophagosome-lysosome fusion (GO:0061909),1/138,0.1172235366155797,0.182506563104744,0,0,8.520824388149421,18.26585775015061,ATG16L1
104,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1479218196071764,0.183141300466028,0,0,6.619652406417113,12.650628330192763,NRG1
394,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0072336),1/142,0.1204195010018536,0.1842302693072665,0,0,8.277430120984564,17.521447135021635,LIMD1
396,GO_Biological_Process_2017b,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),1/143,0.1212167829384625,0.1842302693072665,0,0,8.218724109362055,17.34294402575858,LIMD1
395,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1/142,0.1204195010018536,0.1842302693072665,0,0,8.277430120984564,17.521447135021635,LIMD1
398,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.1212167829384625,0.1842302693072665,0,0,8.218724109362055,17.34294402575858,NRG1
397,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1/143,0.1212167829384625,0.1842302693072665,0,0,8.218724109362055,17.34294402575858,LIMD1
393,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/141,0.119621535957102,0.1842302693072665,0,0,8.336974789915967,17.702918909968414,RNF220
399,GO_Biological_Process_2017b,protein homooligomerization (GO:0051260),1/150,0.126778675360575,0.1919218682335977,0,0,7.82984603237268,16.171078308333918,ATG16L1
400,GO_Biological_Process_2017b,positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway (GO:1902844),1/151,0.1275705121508778,0.1923602604479771,0,0,7.777254901960784,16.014036926399935,LIMD1
105,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),1/190,0.1579285309548332,0.1936859341898898,0,0,6.160286336756925,11.369502600305925,ATG16L1
401,GO_Biological_Process_2017b,"cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)",1/155,0.1307310829477655,0.1963529598784086,0,0,7.573720397249809,15.409588975790411,LIMD1
106,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",3/1598,0.169683858780132,0.2061579592655809,0,0,2.305579937304075,4.0896797176792905,NRG1;ZNF678;LIMD1
402,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),1/164,0.1378028746147865,0.2061660194432158,0,0,7.152291591483219,14.175348854230412,LIMD1
403,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter (GO:0006357),2/736,0.140544773502052,0.2094499931956651,0,0,3.2779291553133514,6.432048200377444,ZNF678;LIMD1
404,GO_Biological_Process_2017b,protein homotetramerization (GO:0051289),1/173,0.1448203066701671,0.2141551253076216,0,0,6.7749658002735975,13.091006050059688,ATG16L1
405,GO_Biological_Process_2017b,membrane repolarization (GO:0086009),1/173,0.1448203066701671,0.2141551253076216,0,0,6.7749658002735975,13.091006050059688,KCND3
107,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.1783581615526625,0.2145032142093704,0,0,5.382897603485839,9.279908801665458,ATG16L1
108,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),1/219,0.1798526949909336,0.2145032142093704,0,0,5.332973556395035,9.149340756756814,KCND3
406,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/179,0.1494685893137094,0.2201787296428873,0,0,6.544613350958361,12.439143799224476,LIMD1
109,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1902427648031118,0.2248323584036776,0,0,5.007606490872211,8.309894188622586,NRG1
407,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1548614260771356,0.227248759339245,0,0,6.294753577106518,11.741129142703194,PTPRB
146,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.2513904363966567,0.2513904363966567,0,0,3.637439881613023,5.022387932343224,NRG1
110,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.2228038383368437,0.2609414322863936,0,0,4.184540242089616,6.282934619193975,NRG1
111,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.2263444052627623,0.262721184679992,0,0,4.1093032957864,6.105181726167229,NRG1
410,GO_Biological_Process_2017b,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1/226,0.1850633684088648,0.2684820837143758,0,0,5.165228758169935,8.714035232942257,RNF220
409,GO_Biological_Process_2017b,protein ubiquitination (GO:0016567),1/226,0.1850633684088648,0.2684820837143758,0,0,5.165228758169935,8.714035232942257,RNF220
408,GO_Biological_Process_2017b,actin ubiquitination (GO:0007014),1/226,0.1850633684088648,0.2684820837143758,0,0,5.165228758169935,8.714035232942257,RNF220
411,GO_Biological_Process_2017b,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/227,0.1858051929744343,0.2685410902234277,0,0,5.142113482561166,8.654467539704264,LIMD1
412,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.1895047592338975,0.2698153263441737,0,0,5.029539088362617,8.36583928133549,NRG1
414,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.1895047592338975,0.2698153263441737,0,0,5.029539088362617,8.36583928133549,NRG1
415,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.1895047592338975,0.2698153263441737,0,0,5.029539088362617,8.36583928133549,NRG1
413,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.1895047592338975,0.2698153263441737,0,0,5.029539088362617,8.36583928133549,NRG1
416,GO_Biological_Process_2017b,histone ubiquitination (GO:0016574),1/235,0.1917168723288018,0.2719539337108559,0,0,4.964303670186023,8.199717193438136,RNF220
418,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.193188445176418,0.2720263768476769,0,0,4.921734795613161,8.091770858187086,NRG1
417,GO_Biological_Process_2017b,protein monoubiquitination (GO:0006513),1/237,0.193188445176418,0.2720263768476769,0,0,4.921734795613161,8.091770858187086,RNF220
112,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),2/1037,0.2389479864309017,0.2748959135930727,0,0,2.2882850241545896,3.2757014778651543,ZNF678;LIMD1
423,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.1990494717477533,0.2752200277234279,0,0,4.758437801350048,7.681079261011621,NRG1
422,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),1/245,0.1990494717477533,0.2752200277234279,0,0,4.758437801350048,7.681079261011621,NRG1
421,GO_Biological_Process_2017b,nervous system development (GO:0007399),1/244,0.1983190487272474,0.2752200277234279,0,0,4.778261922052772,7.730645739869231,NRG1
420,GO_Biological_Process_2017b,ganglion development (GO:0061548),1/244,0.1983190487272474,0.2752200277234279,0,0,4.778261922052772,7.730645739869231,NRG1
419,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),1/244,0.1983190487272474,0.2752200277234279,0,0,4.778261922052772,7.730645739869231,NRG1
424,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.2026921685902864,0.2792485632017255,0,0,4.661705646113867,7.440393900949895,NRG1
425,GO_Biological_Process_2017b,protein autoubiquitination (GO:0051865),1/253,0.2048702704288094,0.2812376830617706,0,0,4.605508870214752,7.301473949210147,RNF220
426,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),1/255,0.2063192149941518,0.2822152119384292,0,0,4.56878184344604,7.211048746604039,NRG1
427,GO_Biological_Process_2017b,neural tube development (GO:0021915),1/259,0.2092096263302128,0.2851504871333505,0,0,4.49703602371181,7.0352464985563365,NRG1
428,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),1/270,0.2171070833728527,0.2948652940844064,0,0,4.310736934178876,6.584066887109633,NRG1
429,GO_Biological_Process_2017b,neurogenesis (GO:0022008),1/272,0.218534957795225,0.2956759627017474,0,0,4.27848925548079,6.506766195493984,NRG1
430,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.2192479723428101,0.2956759627017474,0,0,4.262543252595155,6.468630594433781,NRG1
431,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/991,0.2234221654806449,0.3002480329090772,0,0,2.400530839231547,3.597656792921906,NRG1;LIMD1
433,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1004,0.2277992539969599,0.3039969138705075,0,0,2.367764471057884,3.5026114948800395,ZNF678;LIMD1
432,GO_Biological_Process_2017b,synapse assembly (GO:0007416),1/285,0.2277563622133903,0.3039969138705075,0,0,4.079950289975145,6.036199992352182,NRG1
435,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
448,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),1/329,0.2582105606693922,0.320930044740072,0,0,3.524748923959828,4.772439196593552,NRG1
447,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),1/328,0.2575311981638886,0.320930044740072,0,0,3.535707861126102,4.796592227940982,NRG1
446,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),1/328,0.2575311981638886,0.320930044740072,0,0,3.535707861126102,4.796592227940982,NRG1
445,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),1/328,0.2575311981638886,0.320930044740072,0,0,3.535707861126102,4.796592227940982,NRG1
444,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),1/328,0.2575311981638886,0.320930044740072,0,0,3.535707861126102,4.796592227940982,NRG1
443,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),1/328,0.2575311981638886,0.320930044740072,0,0,3.535707861126102,4.796592227940982,NRG1
442,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
441,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
440,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
439,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
438,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
437,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
436,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
434,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),1/327,0.2568512480614547,0.320930044740072,0,0,3.546734031035727,4.820927183584267,NRG1
450,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),1/330,0.2588893360476438,0.320930044740072,0,0,3.513856606472376,4.748466227535915,NRG1
451,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),1/330,0.2588893360476438,0.320930044740072,0,0,3.513856606472376,4.748466227535915,NRG1
459,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),1/335,0.2622744229860118,0.320930044740072,0,0,3.4603733709052484,4.63123882575208,NRG1
458,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),1/335,0.2622744229860118,0.320930044740072,0,0,3.4603733709052484,4.63123882575208,NRG1
457,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),1/335,0.2622744229860118,0.320930044740072,0,0,3.4603733709052484,4.63123882575208,NRG1
449,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),1/329,0.2582105606693922,0.320930044740072,0,0,3.524748923959828,4.772439196593552,NRG1
455,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/334,0.2615985760079172,0.320930044740072,0,0,3.470941529765059,4.6543385755323365,NRG1
456,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),1/334,0.2615985760079172,0.320930044740072,0,0,3.470941529765059,4.6543385755323365,NRG1
453,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),1/330,0.2588893360476438,0.320930044740072,0,0,3.513856606472376,4.748466227535915,NRG1
452,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),1/330,0.2588893360476438,0.320930044740072,0,0,3.513856606472376,4.748466227535915,NRG1
454,GO_Biological_Process_2017b,central nervous system development (GO:0007417),1/333,0.2609221442988567,0.320930044740072,0,0,3.4815733522324592,4.677609435230168,NRG1
460,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),1/337,0.2636243646110588,0.3215545593822788,0,0,3.4394257703081235,4.585545793046719,NRG1
461,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/344,0.2683308111180761,0.3260358244760215,0,0,3.368032927456697,4.430764152578589,RNF220
462,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),1/345,0.2690008369044981,0.3260358244760215,0,0,3.3580711354309165,4.409284370551608,NRG1
464,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),1/348,0.2710074389331693,0.3264020412308297,0,0,3.3285302593659942,4.345759091830501,NRG1
463,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),1/347,0.2703391503064064,0.3264020412308297,0,0,3.338320299217953,4.366783326963017,NRG1
113,GO_Biological_Process_2018,phosphorylation (GO:0016310),1/386,0.2959783035302231,0.3375191180607808,0,0,2.994194041252865,3.6453388031640617,LIMD1
115,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),1/398,0.3036945000802164,0.3403472845726563,0,0,2.901911394280634,3.458303620413356,RNF220
114,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.3024140385644269,0.3403472845726563,0,0,2.916902457185406,3.4884934470701143,NRG1
465,GO_Biological_Process_2017b,protein polyubiquitination (GO:0000209),1/381,0.2927394469617987,0.3514708720575827,0,0,3.0343653250773994,3.727633826121644,RNF220
466,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.2966243916293408,0.3550223187313673,0,0,2.9862846693081377,3.62919776036838,PTPRB
116,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),1/424,0.3201397912985814,0.3557108792206461,0,0,2.7199276873870115,3.097990919808182,NRG1
467,GO_Biological_Process_2017b,protein phosphorylation (GO:0006468),1/401,0.3056110309726504,0.3646387067368383,0,0,2.8797058823529413,3.4137246640835075,LIMD1
468,GO_Biological_Process_2017b,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1/413,0.3132274480371527,0.3725655670752469,0,0,2.794117647058824,3.243483521263582,LIMD1
117,GO_Biological_Process_2018,nervous system development (GO:0007399),1/455,0.3392682331069789,0.3737700873212479,0,0,2.5301891681782847,2.735044002052133,NRG1
118,GO_Biological_Process_2018,neutrophil degranulation (GO:0043312),1/479,0.3537270465373631,0.3819867511122509,0,0,2.400196898843219,2.494355946913392,PTPRB
119,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),1/479,0.3537270465373631,0.3819867511122509,0,0,2.400196898843219,2.494355946913392,NRG1
120,GO_Biological_Process_2018,neutrophil activation involved in immune response (GO:0002283),1/483,0.3561076019979903,0.3819867511122509,0,0,2.379790090309983,2.4571864351258017,PTPRB
121,GO_Biological_Process_2018,neutrophil mediated immunity (GO:0002446),1/487,0.3584798741207277,0.3819867511122509,0,0,2.3597191963205035,2.420795241124082,PTPRB
122,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),1/506,0.3696358781774415,0.3906720663664015,0,0,2.2687245195107746,2.257918291811353,RNF220
469,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),1/442,0.3313093560685172,0.3928528897035358,0,0,2.6065092703748167,2.879417905717563,NRG1
123,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),1/519,0.3771630883220924,0.3954129151763872,0,0,2.210311151487622,2.155224870869906,NRG1
124,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.4031218621353314,0.4192467366207447,0,0,2.025239883187317,1.8399635978121285,NFIB
471,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.3590716510430721,0.4231521303061434,0,0,2.3547529894914843,2.411816484757892,NFIB
470,GO_Biological_Process_2017b,neutrophil degranulation (GO:0043312),1/487,0.3584798741207277,0.4231521303061434,0,0,2.3597191963205035,2.420795241124082,PTPRB
505,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
506,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
507,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
504,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
508,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
502,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
509,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/722,0.4842352070875041,0.4959841894510899,0,0,1.5714285714285714,1.139575682538001,NFIB
501,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
500,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
499,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
498,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
503,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1/721,0.4837532099670621,0.4959841894510899,0,0,1.5736928104575163,1.142784873110582,NFIB
510,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),1/723,0.4847167791599755,0.4959841894510899,0,0,1.5691706045299003,1.1363784746680536,NFIB
518,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/726,0.486158948639852,0.4959841894510899,0,0,1.5624340770791074,1.12685816405929,NFIB
512,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
513,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
514,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
515,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
516,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
517,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),1/725,0.4856786495626825,0.4959841894510899,0,0,1.564673383165421,1.130019773452194,NFIB
497,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
519,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1/727,0.4866388240637988,0.4959841894510899,0,0,1.5602009398800842,1.1237083055889487,NFIB
520,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),1/728,0.4871182762124091,0.4959841894510899,0,0,1.557973946112145,1.1205701408849242,NFIB
521,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),1/729,0.4875973054306829,0.4959841894510899,0,0,1.5557530704589528,1.11744361324453,NFIB
522,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),1/730,0.4880759120548141,0.4959841894510899,0,0,1.5535382877430808,1.1143286663381513,NFIB
523,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),1/731,0.4885540964858179,0.4959841894510899,0,0,1.5513295729250605,1.1112252439725694,NFIB
524,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/733,0.4895092000326683,0.4959841894510899,0,0,1.5469302475088396,1.1050527508707135,NFIB
511,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/724,0.4851979265596331,0.4959841894510899,0,0,1.566918883736067,1.133193190935309,NFIB
496,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
489,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
494,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
472,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
473,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
474,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
475,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
476,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
477,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
478,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
479,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
495,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
481,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
482,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
480,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
484,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
493,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
483,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
491,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
490,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
492,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
488,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
487,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
486,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
485,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),1/720,0.4832707874982981,0.4959841894510899,0,0,1.575963347786959,1.1460061050690529,NFIB
525,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),1/739,0.4923644136300784,0.4975608718214249,0,0,1.5338753387533874,1.0868061402096492,NFIB
526,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),1/744,0.4947322303753704,0.4986380111414917,0,0,1.5231573113767714,1.0719046114281638,NFIB
527,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),1/756,0.5003725037638211,0.5029991310801666,0,0,1.4980132450331125,1.0372280416115367,NFIB
528,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),1/770,0.5068776612899408,0.5082045661624276,0,0,1.4696703128585635,0.9986198198302556,NFIB
125,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),1/740,0.4928388137103572,0.5084844903360829,0,0,1.531720130542068,1.0838039737777705,NRG1
126,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/848,0.5416809069633209,0.5544765189388324,0,0,1.3289117299812487,0.8147267893870057,NFIB
127,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.6033210645171119,0.6127479561501917,0,0,1.1165882352941177,0.5642184876685615,PTPRB
128,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.6457582943028364,0.6507641725532459,0,0,0.9915891289491668,0.4336516763809753,NFIB
529,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.6638884845651349,0.6638884845651349,0,0,0.942378995891372,0.3860371576961133,NFIB
129,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.7490551439879347,0.7490551439879347,0,0,0.7369867378230913,0.2129469192399496,NFIB
